NOVARTIS

• NOVARTIS $13,968,000 In-house, the client's own filings · 7 filings
• BROWNSTEIN HYATT FARBER SCHRECK, LLP $570,000 Outside firm · 7 filings
• BGR GOVERNMENT AFFAIRS $420,000 Outside firm · 7 filings
• TARPLIN, DOWNS & YOUNG, LLC $420,000 Outside firm · 7 filings
• TIBER CREEK HEALTH STRATEGIES, INC. $420,000 Outside firm · 7 filings
• TODD STRATEGY GROUP $420,000 Outside firm · 7 filings
• FORBES-TATE $350,000 Outside firm · 7 filings
• DLA PIPER LLP (US) $340,000 Outside firm · 7 filings
• CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS $320,000 Outside firm · 8 filings
• MONUMENT ADVOCACY $300,000 Outside firm · 7 filings
• THORN RUN PARTNERS $160,000 Outside firm · 4 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

• H.R. 1672
  Maintaining Investments in New Innovation Act
  47 filings
• S. 832
  EPIC Act of 2025
  23 filings
• H.R. 1492
  To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…
  17 filings
• H.R. 3037
  Access to Breast Cancer Diagnosis Act of 2025
  9 filings
• H.R. 946
  ORPHAN Cures Act
  9 filings
• S. 1500
  Access to Breast Cancer Diagnosis Act of 2025
  9 filings
• H.R. 1
  One Big Beautiful Bill Act
  7 filings
• H.R. 2214
  DRUG Act
  7 filings
• S. 1096
  Preserve Access to Affordable Generics and Biosimilars Act
  7 filings
• S. 1097
  Interagency Patent Coordination and Improvement Act of 2025
  7 filings
• S. 864
  HELP Copays Act
  7 filings
• H.R. 1262
  Mikaela Naylon Give Kids a Chance Act
  6 filings
• H.R. 3152
  Patent Eligibility Restoration Act of 2025
  6 filings
• H.R. 3160
  PREVAIL Act
  6 filings
• H.R. 3269
  ETHIC Act
  6 filings
• H.R. 5376
  Impacts and Outcomes for Health Career Training Act
  6 filings
• H.R. 950
  Saving Seniors Money on Prescriptions Act
  6 filings
• S. 1041
  Affordable Prescriptions for Patients Act
  6 filings
• S. 1095
  Stop STALLING Act
  6 filings
• S. 43
  Skinny Labels, Big Savings Act
  6 filings
• H.R. 5539
  ORPHAN Cures Act
  5 filings
• S. 3131
  ORPHAN Cures Act
  5 filings
• H.R. 5256
  340B ACCESS Act
  5 filings
• S. 1682
  Alex Gate Safety Act of 2025
  5 filings
• S. 2276
  ETHIC Act
  5 filings
• H.R. 2425
  National Poverty Research Center Authorization Act
  4 filings
• H.R. 5371
  Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and E…
  4 filings
• S. 932
  Give Kids a Chance Act of 2025
  4 filings
• H.R. 5391
  Protecting Patient Access to Cancer and Complex Therapies Act
  3 filings
• S. 2764
  Protecting Patient Access to Cancer and Complex Therapies Act of 2023
  3 filings

• 2026 $7,830,000 30 filings
• 2025 $9,858,000 45 filings

• Health Issues 63
• Medicare/Medicaid 46
• Trade (domestic/foreign) 42
• Taxation/Internal Revenue Code 31
• Budget/Appropriations 21
• Copyright/Patent/Trademark 20
• Labor Issues/Antitrust/Workplace 7
• Medical/Disease Research/Clinical Labs 2
• Pharmacy 2
• Tariff (miscellaneous tariff bills) 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

• HOUSE OF REPRESENTATIVES 64
• SENATE 63
• Health & Human Services, Dept of (HHS) 27
• Centers For Medicare and Medicaid Services (CMS) 15
• Executive Office of the President (EOP) 11
• U.S. Trade Representative (USTR) 10
• Commerce, Dept of (DOC) 8
• Congressional Budget Office (CBO) 7
• Food & Drug Administration (FDA) 7
• Office of Management & Budget (OMB) 7
• Patent & Trademark Office (PTO) 7
• White House Office 7
• Treasury, Dept of 5
• Health Resources & Services Administration (HRSA) 2
• Indian Health Service 1
• State, Dept of (DOS) 1
• U.S. Agency for International Development (USAID) 1

• NOVARTIS INTERNATIONAL AG Switzerland named on 3 filings · highest disclosed ownership 100% · largest disclosed contribution $0
• NOVARTIS AG Switzerland named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.